Puze Long
YOU?
Author Swipe
View article: Ramifications of lymph node metastasis in patients with pT1 colorectal cancer
Ramifications of lymph node metastasis in patients with pT1 colorectal cancer Open
LNM does not affect the long-term survival of patients with pT1N1CRC after radical resection. Appropriate downstaging from stage IIIA may be a reasonable prospect for pT1N1CRC with a low recurrence factor.
View article: CISD2 protects against Erastin induced hepatocellular carcinoma ferroptosis by upregulating FSP1
CISD2 protects against Erastin induced hepatocellular carcinoma ferroptosis by upregulating FSP1 Open
Objectives CDGSH iron sulfur domain 2 (CISD2) is essential to maintain iron (Fe) and reactive oxygen species (ROS) homeostasis, and ferroptosis suppressor protein 1 (FSP1) can protect cells from ferroptosis by inhibiting lipid peroxidation…
View article: ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma Open
Hepatocellular carcinoma (HCC) is one of the common malignant tumors. The prognosis and five-year survival rate of HCC are not promising due to tumor recurrence and metastasis. Exploring markers that contribute to the early diagnosis of HC…
View article: Prognostic value of LINC02560 in colorectal cancer correlates with tumor microenvironment immunity
Prognostic value of LINC02560 in colorectal cancer correlates with tumor microenvironment immunity Open
Background: LINC02560 is a new 477 bp long non-coding RNA located in 19q13.43. However, the expression of LINC02560 in colorectal cancer (CRC) has not been reported, and its correlation with tumor development and function is still unclear.…
View article: Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics
Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics Open
Peiyun Long,1,* Youya Zang,1,* Huan Wang,1 Xiumei Liang,1 Xuekun Xie,1 Zhiwei Han,1 Dongyi Lin,1 Zongyu Wang,1 Shan Huang,2 Chuang Chen1 1Department of Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People’s …